, including OSO BioPharmaceuticals Manufacturing, LLC; Par Pharmaceutical Companies, Inc.; Jubilant Hollister-Stier Laboratories LLC (a subsidiary of Jubilant Life Sciences Limited); Patheon Inc.; Hospira Inc.; Ajinomoto Althea, Inc. (a subsidiary of Ajinomoto Co., Inc.); Cook Pharmica LLC (a subsidiary of Cook Group Inc.); and Albany Molecular Research, Inc. Regulations The company’s status as a U.S. government contractor means that it is subject to various statutes and regulations, including the Federal Acquisition Regulation. History The company was founded in 1998. It was incorporated in the state of Michigan in 1998 and subsequently reorganized as a Delaware corporation in 2004.
emergent biosolutions inc (EBS:New York)
400 Professional Drive
Gaithersburg, MD 20879
|Albany Molecular Research Inc||$14.16 USD||+0.38|
|Depomed Inc||$20.13 USD||+0.32|
|Green Cross Corp/South Korea||173,500 KRW||-2,500.00|
|Insys Therapeutics Inc||$15.20 USD||+0.87|
|Nektar Therapeutics||$14.54 USD||+0.47|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact EMERGENT BIOSOLUTIONS INC, please visit www.emergentbiosolutions.com. Company data is provided by Capital IQ. Please use this form to report any data issues.